Projects funded by the NCN

The new tools for research mechanisms of anticancer activity of photosenthisisers used for photodynamic therapy of cance...

Call: OPUS 8 , Panel: NZ5

Principal investigator: dr hab. Marek Arkadiusz Murias

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Hydrogel microspheres containing dextran-based nanoparticles. Study on targeting effect in novel anticancer drug deliver...

Call: PRELUDIUM 7 , Panel: NZ5

Principal investigator: Aleksandra Anna Kulikowska

Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

The examination of isothiocyanates influence on cytotoxic and cytostatic effects of 5-fluorouracil in cancer cell lines ...

Call: PRELUDIUM 3 , Panel: NZ5

Principal investigator: Małgorzata Milczarek

Narodowy Instytut Leków

The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance...

Call: PRELUDIUM 3 , Panel: NZ5

Principal investigator: dr Magdalena Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Combined induction of cell death of canine leukemia and lymphoma.

Call: OPUS 2 , Panel: NZ5

Principal investigator: dr hab. Andrzej Marek Rapak

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra...

Call: OPUS 28 (LAP) , Panel: NZ5

Principal investigator: dr Marcin Skoreński

Politechnika Wrocławska

FA-PROTACs - Design and Synthesis of Compounds Based on Folic Acid for Degradation of Enzyme Involved in Folate Metaboli...

Call: SONATA 20 , Panel: NZ5

Principal investigator: dr Mateusz Daśko

Politechnika Gdańska

Potential pharmacological strategies aimed at alleviating cognitive dysfunctions accompanying oncological therapy while ...

Call: OPUS 26 , Panel: NZ5

Principal investigator: dr hab. Joanna Monika Wierońska

Instytut Farmakologii PAN

Tumor viscoelasticity as a central player in glioblastoma treatment - towards mechanopharmacology

Call: OPUS 26 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Pogoda

Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

Call: OPUS 25 , Panel: NZ7

Principal investigator: prof. Błażej Rubiś

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen...

Call: OPUS 25 , Panel: NZ7

Principal investigator: prof. Ryszard Józef Ostaszewski

Instytut Chemii Organicznej Polska Akademia Nauk

Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy

Call: OPUS 23 , Panel: NZ5

Principal investigator: dr Martyna Krzykawska-Serda

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Evaluation of NOTCH1- and NOTCH3-dependent anticancer drug resistance in a 2D and 3D model of Head and Neck Squamous Cel...

Call: PRELUDIUM 20 , Panel: NZ5

Principal investigator: dr Joanna Elżbieta Kałafut

Uniwersytet Medyczny w Lublinie

Effects of receptor action of L- and D-Lactate on cervical cancer cells. Lactate modulation of cell DNA repair response ...

Call: OPUS 2 , Panel: NZ4

Principal investigator: dr Waldemar Wagner

Instytut Biologii Medycznej PAN

Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

Call: OPUS 19 , Panel: NZ7

Principal investigator: dr hab. Janusz Marcin Dąbrowski

Uniwersytet Jagielloński, Wydział Chemii

Tyrosine-modified polyethylenimine polymers as a promising vectors for siRNA delivery in synergistic cancer immunotherap...

Call: PRELUDIUM 19 , Panel: NZ5

Principal investigator: Małgorzata Kubczak

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Evaluation of endoplasmic reticulum stress control by endogenous lipids in the context of its anticancer therapeutic pot...

Call: OPUS 17 , Panel: NZ5

Principal investigator: dr Dariusz Maciej Pytel

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

DEVELOPMENT OF NEW CLASS PHOTOACTIVATED ANTICANCER-ANTIFUNGAL COMPOUNDS: CONJUGATES OF GOLD NANOPARTICLE-SUPPORTED QUINO...

Call: OPUS 17 , Panel: NZ7

Principal investigator: dr hab. Oleh M. Demchuk

Katolicki Uniwersytet Lubelski Jana Pawła II, Wydział Medyczny

STING protein activation combined with anti-vascular agent as a novel strategy for anticancer therapy

Call: OPUS 16 , Panel: NZ5

Principal investigator: dr hab. Ryszard Smolarczyk

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Effectiveness of anticancer activity of DMU-214 (3'-hydroxy-3,4,5,4'-tetrametoxystilbene) in personalized treatment for ...

Call: SONATA 12 , Panel: NZ7

Principal investigator: dr hab. Hanna Helena Piotrowska-Kempisty

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

The contribution of ultrashort electric pulses in the induction of oxidative stress and to assessment of the anticancer ...

Call: SONATA BIS 6 , Panel: NZ5

Principal investigator: dr hab. Julita Kulbacka

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

Evaluation of anticancer potential of glutamine metabolism modulation in multiple myeloma sensitive and resistant to che...

Call: PRELUDIUM 11 , Panel: NZ5

Principal investigator: Monika Katarzyna Prełowska

Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

AP-1 : a novel player in the regulation of Senescence Associated Secretory Phenotype of cancer cells

Call: PRELUDIUM 10 , Panel: NZ3

Principal investigator: Anna Aneta Strzeszewska

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Mesenchymal stromal cells (MSC) as carriers of IL-12 cDNA in treatment of mice with melanoma B16-F10 and metastases

Call: PRELUDIUM 9 , Panel: NZ4

Principal investigator: Natalia Iwona Kułach

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach